University of California at Los Angeles UCLA and TRIO Network — Los Angeles, California

University of California at Los Angeles UCLA and TRIO Network is a clinical research site located in Los Angeles, California, United States 90095-6956.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

University of California at Los Angeles UCLA and TRIO Network has participated in 1 clinical trials.

Therapeutic areas: Advanced Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for University of California at Los Angeles UCLA and TRIO Network?

University of California at Los Angeles UCLA and TRIO Network has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has University of California at Los Angeles UCLA and TRIO Network conducted?

University of California at Los Angeles UCLA and TRIO Network has 1 clinical trials on record. Their work covers Advanced Breast Cancer.

Is University of California at Los Angeles UCLA and TRIO Network accredited by Crixeo Health?

University of California at Los Angeles UCLA and TRIO Network has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about University of California at Los Angeles UCLA and TRIO Network?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.